Indaptus Therapeutics Statistics
Total Valuation
INDP has a market cap or net worth of $6.35 million. The enterprise value is $535,551.
Important Dates
The next estimated earnings date is Thursday, March 12, 2026, before market open.
| Earnings Date | Mar 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INDP has 2.24 million shares outstanding. The number of shares has increased by 97.19% in one year.
| Current Share Class | 2.24M |
| Shares Outstanding | 2.24M |
| Shares Change (YoY) | +97.19% |
| Shares Change (QoQ) | +73.42% |
| Owned by Insiders (%) | 88.25% |
| Owned by Institutions (%) | 3.32% |
| Float | 188,401 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.01 |
| P/TBV Ratio | 1.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.00.
| Current Ratio | 2.88 |
| Quick Ratio | 2.61 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -317.98% and return on invested capital (ROIC) is -184.71%.
| Return on Equity (ROE) | -317.98% |
| Return on Assets (ROA) | -131.38% |
| Return on Invested Capital (ROIC) | -184.71% |
| Return on Capital Employed (ROCE) | -344.12% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.41M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.30% in the last 52 weeks. The beta is 1.01, so INDP's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | -88.30% |
| 50-Day Moving Average | 2.50 |
| 200-Day Moving Average | 6.76 |
| Relative Strength Index (RSI) | 51.42 |
| Average Volume (20 Days) | 2,079,736 |
Short Selling Information
The latest short interest is 260,406, so 11.61% of the outstanding shares have been sold short.
| Short Interest | 260,406 |
| Short Previous Month | 17,701 |
| Short % of Shares Out | 11.61% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.14 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.85M |
| Pretax Income | -16.87M |
| Net Income | -16.87M |
| EBITDA | -15.85M |
| EBIT | -15.85M |
| Earnings Per Share (EPS) | -$27.45 |
Full Income StatementBalance Sheet
The company has $5.83 million in cash and $8,686 in debt, with a net cash position of $5.82 million or $2.59 per share.
| Cash & Cash Equivalents | 5.83M |
| Total Debt | 8,686 |
| Net Cash | 5.82M |
| Net Cash Per Share | $2.59 |
| Equity (Book Value) | 4.61M |
| Book Value Per Share | 2.81 |
| Working Capital | 4.20M |
Full Balance SheetCash Flow
| Operating Cash Flow | -15.03M |
| Capital Expenditures | n/a |
| Free Cash Flow | -15.03M |
| FCF Per Share | -$6.70 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
